Hangzhou SDIC Microelectronics (SH:688130) Dong Jian Yan Bao·2025-03-07 01:03Investment Rating - The report does not explicitly state an investment rating for the semiconductor industry or the specific company being analyzed [1]. Core Insights - The company achieved a revenue of 134.85 million yuan in 2024, representing a year-on-year growth of 6.34%. The net profit attributable to the parent company was a loss of 10.27 million yuan, which is a reduction in loss by 49.54% year-on-year. The net profit after deducting non-recurring gains and losses was a loss of 27.76 million yuan, a reduction in loss by 20.91% year-on-year. Despite intensified competition in the domestic semiconductor industry, the company increased its sales volume, leading to revenue growth [16][18]. - In 2024, the company launched a blood glucose meter chip with HCT functionality, designed to meet ISO15197:2013 standards. The company is actively promoting this product to well-known brand clients [16][18]. - The company acquired 100% equity of Shenzhen Chipon Intelligent Microelectronics Co., Ltd. to enhance its core business focus and expand its strategic layout. This acquisition aims to integrate technology, products, markets, and supply chains effectively [18]. - The company's gross margin for the first three quarters of 2024 was 58.27%, indicating a stable profitability outlook [18]. Summary by Sections 1. Basic Research Information - The research was conducted on the company Jinghua Micro in the semiconductor industry on March 4, 2025. The meeting was attended by representatives from various investment institutions [9][13]. 2. Detailed Research Institutions - The institutions involved in the research include Hejun Capital, Shanghai Securities Research, Tianfeng Asset Management, and AVIC Industry Finance [14]. 3. Main Content Information - The company discussed its 2024 business performance, new product launches, and the acquisition of Shenzhen Chipon Intelligent Microelectronics Co., Ltd. during the Q&A session [16][18].